Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease Frontiers Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One